Microcap Ledger

Tickers · $COSM

Cosmos Health Inc. $COSM

By Microcap Ledger desk · CIK 0001474167

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Headquarters
Thessaloniki, Greece
Fiscal year end
December 31
Shares outstanding
100,633,773 [10-Q 2026-08-18]
as of 2026-08-18

Sources: [10-K 2026-04-15]

What the company doesAI summary of filing

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company that develops, manufactures, and distributes pharmaceutical and nutraceutical products. The company generates revenue through multiple business segments: generic medicines (therapeutic equivalents of branded drugs sold at lower prices), proprietary nutraceutical brands (Sky Premium Life and Mediterranation), biocides and antiseptic products (C-Sept and C-Scrub), pharmaceutical manufacturing for third parties under GMP/EMA certification, wholesale pharmaceutical distribution to pharmacies and hospitals, and a telehealth platform (ZipDoctor). The company is also developing novel medicines through research and development activities, including obesity treatment CCX0722, cancer treatments targeting CNS, prostate, ovarian and colorectal cancers, and operates an AI-powered drug repurposing platform (Cloudscreen). Cosmos Health is revenue-generating, with the majority of revenues currently from European Union operations, particularly Greece, with growing contributions from the UAE and initial U.S. operations commencing in 2026. [10-K 2026-04-15]

Segments: Generic Medicines, Nutraceuticals, Biocides, Pharmaceutical Manufacturing & Wholesale Distribution

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$36.91M−$8.89M −$2.79M$1.80M[10-Q 2026-08-18]
FY ended Dec 2025$65.27M−$19.14M −$8.45M$715.7K[10-K 2026-04-15]
FY ended Dec 2024$54.43M−$16.18M −$7.72M$315.1K[10-K 2026-04-15]
Quarterly cash burn
−$1.39M
Cash runway Estimate
~3.9 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-1423,346,049[10-Q 2024-11-14]
2025-04-1527,284,658[10-K 2025-04-15]
2025-05-1528,751,422[10-Q 2025-05-15]
2025-08-1430,213,876[10-Q 2025-08-18]
2025-11-1434,919,920[10-Q 2025-11-14]
2026-04-1450,824,657[10-K 2026-04-15]
2026-05-1854,428,491[10-Q 2026-05-20]
2026-08-18100,633,773[10-Q 2026-08-18]
Shelf registration
S-3 filed 2025-11-07; no effectiveness notice found in EDGAR [S-3 2025-11-07]

Listing status

Current status: 3 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-12-18. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2025-12-188-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-12-18]
2025-05-078-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-05-07]
2024-11-128-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2024-11-12]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-07-30Siokas Grigoriosbuy349,825$0.20[4 2026-07-31]
2026-07-29Terzis Georgiosgrant328,407$0.18[4 2026-07-30]
2026-07-29Siokas Grigoriosbuy766,284$0.18[4 2026-07-30]
2026-06-16Terzis Georgiosbuy168,135$0.25[4 2026-06-17]
2026-06-11Siokas Grigoriosbuy218,447$0.21[4 2026-06-12]
2026-06-10Siokas Grigoriosbuy701,447$0.23[4 2026-06-12]
2026-05-19Karkantzos Theodoros Christosgrant20,000$0.28[4 2026-06-11]
2026-05-19Hoidas John Jamesgrant20,000$0.28[4 2026-06-11]

Catalysts and calendar

Facts as of . Small caps move fast; check the latest filings.